NASDAQ
BioRestorative Therapies, Inc. (BRTX) has a free cash flow growth of -52.63% as of Friday, May 29, 2026. This represents a 2332.62% decrease compared to its 12-month average of -2.16%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.